StockData
LB Pharmaceuticals Inc logo

LB Pharmaceuticals Inc (LBRX) SEC filings

LBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$40.30−2.69 (-6.26%)

Close on Nov 17, 2026Market cap $1.30BP/E –Yield –

SEC filings

23 of LB Pharmaceuticals's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Quarterly report10-QSep 30, 2026Nov 5, 2026SEC EDGAR
Current report8-KNov 5, 2026Nov 5, 2026SEC EDGAR
Current report8-KSep 15, 2026Sep 15, 2026SEC EDGAR
Current report8-KSep 3, 2026Sep 3, 2026SEC EDGAR
Quarterly report10-QJun 30, 2026Aug 11, 2026SEC EDGAR
Current report8-KAug 11, 2026Aug 11, 2026SEC EDGAR
Current report8-KJul 28, 2026Jul 29, 2026SEC EDGAR
Current report8-KJul 22, 2026Jul 22, 2026SEC EDGAR
Current report8-KJun 8, 2026Jun 10, 2026SEC EDGAR
Current report8-KJun 3, 2026Jun 9, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 12, 2026SEC EDGAR
Current report8-KMay 12, 2026May 12, 2026SEC EDGAR
Proxy statementDEF 14AJun 3, 2026Apr 23, 2026SEC EDGAR
Annual report10-KDec 31, 2025Mar 26, 2026SEC EDGAR
Current report8-KMar 26, 2026Mar 26, 2026SEC EDGAR
Current report8-KMar 13, 2026Mar 16, 2026SEC EDGAR
Current report8-KMar 4, 2026Mar 10, 2026SEC EDGAR
Current report8-KFeb 4, 2026Feb 5, 2026SEC EDGAR
Current report8-KNov 10, 2025Nov 13, 2025SEC EDGAR
Current report8-KNov 12, 2025Nov 12, 2025SEC EDGAR
Quarterly report10-QSep 30, 2025Nov 6, 2025SEC EDGAR
Current report8-KNov 6, 2025Nov 6, 2025SEC EDGAR
Current report8-KSep 12, 2025Sep 12, 2025SEC EDGAR

See a number that looks wrong?